Oragenics Advances Concussion Drug ONP-002 in Phase IIa Trial
May 18, 2026 — Oragenics (OGEN) provides shareholder update on Phase IIa trial of ONP-002 for concussion in Australia, plans FDA meeting; stock news.
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 18, 2026 — Oragenics (OGEN) provides shareholder update on Phase IIa trial of ONP-002 for concussion in Australia, plans FDA meeting; stock news.
May 18, 2026 — NanoViricides highlights NV-387's potential against Ebola outbreak; oral broad-spectrum antiviral targets filoviruses. Learn about the company's pandemic preparedness tool and clinical pipeline.
May 18, 2026 — Lantern Pharma (LTRN) reports Q1 2026 results: 47% R&D cost reduction, FDA meeting for LP-300, IND clearance for Starlight, and launch of withZeta.ai AI platform. Read the full update.
May 18, 2026 — Learn what makes the best orthodontist in Hudson Valley NY. Van Vliet & Ganz Orthodontics offers board-certified care, Invisalign, and emergency services. Use our checklist to find top orthodontic care.
May 18, 2026 — Quantum BioPharma (QNTM) announces halfway enrollment in MS imaging study with MGH, showing promising PET tracer data for demyelination. Lucid-MS Phase 2 IND submitted.
May 18, 2026 — Fairhope Children's Dentistry launches free consultations for new pediatric patients, lowering barriers to early dental care in Fairhope, AL. Learn how this gentle dentist for kids promotes preventive oral health.
May 18, 2026 — San Elijo Pediatric Dentistry & Orthodontics expands integrated care in San Marcos, offering pediatric dentist and orthodontist services under one roof with oral conscious sedation for kids.
May 18, 2026 — Bonita Springs gets non-surgical body contouring from expert Kristi at Anne Therese Aesthetic Medicine. Schedule a consultation for personalized, natural results.
May 18, 2026 — American Heart Association launches initiative with T-Mobile to close communication gaps in cardiac and stroke emergency response using technology, targeting 13 cities to improve survival rates.
May 18, 2026 — Learn how international collaboration can reduce Kawasaki disease heart risks. New advisory stresses early diagnosis, treatment access for children worldwide.
May 18, 2026 — Feldman Orthodontics offers Invisalign for adults in Wallingford CT, providing clear aligners for working professionals seeking discreet, flexible orthodontic care without metal braces.
May 16, 2026 — Door Services Corporation expands Horton product line with HD Storm™ sliding door for high-wind areas and Behavioral Health Profiler® ICU for safety in psychiatric facilities. Learn more.
May 16, 2026 — Radiant Smiles in San Diego expands cosmetic and restorative dentistry under Dr. Raymond Wright III, including dental implants, Invisalign, and teeth whitening. Learn more.
May 15, 2026 — Vycor Medical Q1 2026 results show 5% revenue growth, operating profit of $45,808, and new clinical studies validating ViewSite Brain Access System for safer neurosurgery.
May 15, 2026 — Cardio Diagnostics Holdings uses AI, epigenetics, and genetics for personalized cardiovascular risk assessments. Learn how precision medicine is transforming heart disease prevention.
May 15, 2026 — Cardio Diagnostics (CDIO) develops AI-powered solutions to prevent 80% of cardiovascular disease cases. Learn about Epi+Gen CHD and PrecisionCHD in this news summary.
May 15, 2026 — Oncotelic Therapeutics featured in NetworkNewsAudio for CNS drug delivery breakthroughs; discusses blood-brain barrier challenges, N2B delivery system for Alzheimer's and biodefense. Learn about OTLC's AI platform and pipeline.
May 15, 2026 — SureNano Science (SURNF) advances GEP-44, a next-generation GLP-1 therapy targeting obesity with improved tolerability and potential non-injectable delivery. Learn about the triple agonist mechanism and market impact.
May 15, 2026 — Oncotelic Therapeutics (OTLC) reports Q1 2026 results with advances in oncology, AI drug development, and nose-to-brain CNS delivery. Learn about its PDAOAI platform and GMP Biotech joint venture.
May 15, 2026 — Annovis Bio reports 85% enrollment in Phase 3 Alzheimer's trial and 40% in Parkinson's study. Learn about buntanetap's progress and AI monitoring in neurodegenerative disease treatments.